Upadacitinib
Composition
This formulation contain Ubadacitinib as active agent
Indications
It is indicated for the treatment of moderate to severe rheumatoid arthritis (RA)
Side effects
upper respiratory tract infections, nausea, headache, and hypertension
Precautions
used with caution in patients with a history of serious infections, gastrointestinal disorders, or malignancies
Contraindications
It is contraindicated in patients with active serious infections.
Dosage and administration
directed by a healthcare professional
Countries
Worldwide
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai